Filing Details

Accession Number:
0001371285-22-000116
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-14 19:32:55
Reporting Period:
2022-04-12
Accepted Time:
2022-04-14 19:32:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1371285 Trupanion Inc. TRUP Hospital & Medical Service Plans (6324) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611679 Darryl Rawlings C/O Trupanion, Inc.
6100 4Th Avenue South, Suite 200
Seattle WA 98108
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-12 4,000 $14.95 561,350 No 4 M Direct
Common Stock Disposition 2022-04-13 4,000 $84.86 853,109 No 4 S Indirect By Kuyashii Primary Equities LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Indirect By Kuyashii Primary Equities LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2022-04-12 4,000 $0.00 4,000 $14.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
46,000 2026-08-08 No 4 M Direct
Footnotes
  1. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by Kuyashii Primary Equities LLC, a limited liability company indirectly, wholly-owned by the reporting person and reporting person's spouse, on November 8, 2021, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. In aggregate, the reporting person's plan is Rule 10b5-1 trading plan is part of a diversification strategy on the part of the reporting person to diversify up to 25% of the reporting person's holdings as of the date of the Company's initial public offering in July 2014 from the inception of the Rule 10b5-1 trading plan through 2025.
  2. The option vested as to 25% of the total shares on August 8, 2017, and then 2.0833% of the total shares vested monthly thereafter, with 100% of the total shares vested and exercisable on August 8, 2020.